
HotCopper editor Isaac McIntyre breaks down uranium deals, PFS misses, and an Ebola biotech play from the ASX penny stock watchlist. Full episode on Spotify.
Alpha Score of 50 reflects moderate overall profile with weak momentum, weak value, strong quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
HotCopper editor Isaac McIntyre walked through the biggest sub-$1 movers on the ASX and the forum's trending stocks for the week ahead, with a focus on uranium deals, pre-feasibility study misses, and a biotech play tied to Ebola.
Minerals 260 (ASX:MI6) was among the names in the spotlight. Alligator Energy (ASX:AGE) and Austral Resources (ASX:AAR) also featured in the episode, which drew from the HotCopper HotList tracking page.
The podcast, recorded after the RIU Resources Round-Up in Sydney, included video interviews with multiple ASX-listed companies that attended the conference. Those interviews are available on HotCopper.com.
McIntyre noted that the uranium sector saw deal activity that caught forum attention, while some pre-feasibility studies fell short of market expectations. A biotech name tied to Ebola response efforts was flagged as an opportunity the forum is watching.
The HotList section, which tracks the most-followed stocks on Australia's largest stock forum, is accessible through the "My Account" menu on the HotCopper home page. Users can navigate to "My Profile," then "My Watchlist," and scroll to the bottom. A direct link is also available.
The episode is available for streaming and download on Spotify.
Disclaimer: Any information or advice in this HotCopper podcast recording is intended for education and entertainment purposes. Any advice is general in nature and does not take into consideration your objectives, financial situation or needs. Before acting on general advice, you should consider whether it is relevant to your needs and read the relevant Product Disclosure Statement. If you are unsure, please speak to a financial professional. The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions.
Prepared with AlphaScala editorial tooling from the source reporting linked above. Indexable analysis may include a cited Alpha Score value. Publishing checks screen each story before release. Educational coverage, not personalized advice.